NCT04803201 · Interventional trial
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Overall registry status Recruiting
Phase 2
Conditions Angioimmunoblastic T-cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Follicular T-Cell Lymphoma, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Peripheral T-Cell Lymphoma, Not Otherwise Specified
Delaware Valley sites
- Cooper Hospital University Medical Center · Camden, NJ · Camden County · Recruiting
- University of Pennsylvania/Abramson Cancer Center · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory